Evidence map›Paper›PMID 41085335›Full record

ArticleEpilepsia2026

Rigorous evaluation of five models for e-diary-only seizure forecasting: Retrospective and prospective datasets do not outperform the Napkin method.

Chi-Yuan Chang, Robert Moss, M Brandon Westover, Daniel M Goldenholz

Abstract read
In one paragraph

Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chi-Yuan ChangHarvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-0843-755X
Robert MossSeizure Tracker, Springfield, Virginia, USA.ORCID https://orcid.org/0000-0002-9407-5681
M Brandon WestoverHarvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0003-4803-312X
Daniel M GoldenholzHarvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-8370-2758

Funding

Late-onset Unexplained Epilepsy as a Risk Factor for DementiaR01NS130119 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Alice D Lam · 2023 to 2026
$8.7M
Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and MortalityR01HL161253 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CLIFFORD, GARI DAVID, MIGNOT, EMMANUEL J · 2022 to 2025
$8.3M
Comparative Safety of Seizure Prophylaxis within the Medicare ProgramR01AG073410 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Lidia Maria Veras Rocha de Moura · 2021 to 2026
$4.1M
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and InattentionR01AG073598 · NIA · STANFORD UNIVERSITY · PI Miles Berger · 2022 to 2026
$3.8M
Integrative Motor Activity Biomarker for the Risk of Alzheimer's RiskRF1AG064312 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, KUN · 2019 to 2019
$3.6M
Prospective Validation of Neurophysiologic Outcome Prediction in Acute Brain InjuryR01NS126282 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Aaron F Struck, Michael Brandon Westover · 2023 to 2026
$2.9M
Establishing a Brain Health Index from the Sleep ElectroencephalogramRF1NS120947 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, THOMAS, ROBERT JOSEPH · 2021 to 2021
$2.4M
Comparative Effectiveness of EEG-Guided Anti-Seizure Treatment in Acute Brain InjuryR01NS131347 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Sahar F Zafar · 2024 to 2026
$1.9M
Non-Invasive Seizure Forecasting System Using E-Diaries, Internal and External FactorsK23NS124656 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Daniel M Goldenholz · 2022 to 2026
$954k
National Science Foundation 2014431NIH HHS R01AG073410NIH HHS R01AG073598NIH HHS R01HL161253NIH HHS R01NS126282NIH HHS R01NS130119NIH HHS R01NS131347NIH HHS RF1AG064312NIH HHS RF1NS120947NINDS NIH HHS K23 NS124656NINDS NIH HHS K23NS124656
6 · The paper itself

Abstract

objectiveSeizure forecasting using e-diaries may help patients with seizures to organize their daily life. Until now, most methods were not rigorously tested against a strict standard. This study aims to assess whether the performance of various models for seizure forecasting using e-diaries is better than the performance of a moving window average (a.k.a. the Napkin method, due to simplicity of calculation).

methodsWe analyzed three cohorts from Seizure Tracker: a retrospective study and two prospective studies. E-diaries and the type of seizures were extracted from the datasets. We implemented five machine learning models (Perceptron, 1D-convolution, Multilayer Perceptron, Cycle, point-process generalized linear model) and compared their performance at seizure forecasting against the Napkin forecast. The models predicted the probability of having at least one seizure in the next 24-h period based on a 90-day historical window. Model performances were evaluated by commonly used metrics (area under the precision-recall curve, area under the receiver operating characteristic curve, and Brier score). We considered a model to be clinically ineffective if it did not outperform the Napkin method across metrics and seizure frequencies.

resultsA total of 5501 retrospective patients (3300 training, 1100 validation, and 1101 testing) and 36 prospective patients (21 from one cohort, 15 from the other) were included in the analysis. No model achieved significantly better performance than the Napkin method across metrics and frequencies. SIGNIFICANCE: Clinically effective seizure forecasting (i.e., beyond the Napkin method) for 24-h risk using e-diaries alone may be infeasible with currently available techniques.

Indexed as

Machine LearningSeizuresAdultFemaleForecastingHumansMaleMiddle AgedProspective StudiesRetrospective Studiesbiostatisticsforecastingmachine learningseizure diary

Identifiers

PMID41085335
PMCPMC12959853

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.